论文部分内容阅读
支气管哮喘发作期的药物治疗是必要的,且效果肯定。而静息期的药物防治是否有必要?该怎样用药?则文献报道甚少。本文根据支气管哮喘诊断标准(试行方案)在专科门诊随机抽取支气管哮喘静息期患者17名,选用支气管扩张剂氨茶碱十舒喘灵雾化吸入,观察用药前后肺通气功能各指标的变化。结果提示支气管哮喘患者在静息期仍有不同程度的阻塞性通气功能障碍者,该期的药物应用对于解除这种阻塞效果显著。因此,认为对于该病例静息期用药对于防治哮喘的发作是有效的,且亦必要。
Bronchial asthma exacerbation of drug treatment is necessary, and the effect is certain. The rest period of drug prevention and treatment is necessary? How to use medicine? The literature reported little. In this paper, according to the diagnostic criteria for bronchial asthma (trial program) in the specialist outpatient at random bronchial asthma in patients with resting period 17, the choice of bronchial dilation agent aminophylline Shuxu Ling atomized inhalation, before and after treatment to observe the changes in pulmonary function indicators. The results suggest that patients with bronchial asthma at rest still have varying degrees of obstructive ventilatory dysfunction, the drug application of this period to relieve this obstruction significant effect. Therefore, it is considered effective for the prevention and treatment of the onset of asthma and is also necessary for the rest period of the case.